4//SEC Filing
Craig Kevin James 4
Accession 0001140361-25-009514
CIK 0001840904other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 7:29 PM ET
Size
6.6 KB
Accession
0001140361-25-009514
Insider Transaction Report
Form 4
Craig Kevin James
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Shares
2025-03-14+20,000→ 20,000 total - Exercise/Conversion
Restricted Stock Units
2025-03-14−20,000→ 0 total→ Common Shares (20,000 underlying)
Footnotes (1)
- [F1]Each restricted stock unit represents a contingent right to receive one common share of the Issuer upon vesting and settlement. The restricted stock units vested on March 14, 2025.
Documents
Issuer
ATAI Life Sciences N.V.
CIK 0001840904
Entity typeother
Related Parties
1- filerCIK 0002049601
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 7:29 PM ET
- Size
- 6.6 KB